German CDMO ProBioGen has announced significant expansion of its biomanufacturing capabilities through commissioning of an additional 1000L GMP production line for protein therapeutics and completion of a new viral vector manufacturing unit at its Berlin facilities.

A new temperature-controlled version of the DrySyn Vortex Parallel Overhead Stirring System has been introduced by Asynt, offering lab scientists enhanced control for multiple parallel reactions. The system enables active heating or cooling whilst maintaining efficient overhead stirring for viscous or heterogeneous reaction mixtures.  

Cambridge-based Sphere Fluidics has introduced a new high-sensitivity assay designed for single-cell detection of Fc fusion proteins, potentially accelerating the development of this important class of biologic therapeutics. The technology leverages microfluidic capabilities to enable rapid screening of therapeutic protein-producing cell lines.  

Laboratory equipment manufacturer Asynt has introduced an expanded portfolio of photochemistry reactors, offering researchers enhanced capabilities for both batch and continuous flow applications. This development addresses the growing interest in photochemistry as a ‘reagentless’ activation method in synthetic chemistry.

The CE-marked assay provides fast and simple real-time PCR-based detection of SARS-CoV-2 in RNA isolated from the patient samples. Reverse transcription and real-time PCR are performed in one step, so that only one reaction is required per sample.